CATALYST PHARMACEUTICALS, INC.
CATALYST PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 4193720, and its current status with Delaware Division of Corporations is active. The company was incorporated on 7 September 2007 and lists its registered address as United States. 5 shareholders are on record for CATALYST PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for CATALYST PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 10.7% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Small-Cap ETF at 8.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 9 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 10.7% | Delaware Division of Corporations | |
| iShares Trust-iShares Core S&P Small-Cap ETF | 8.7% | Delaware Division of Corporations | |
| iShares Trust-iShares Russell 2000 ETF | 3.7% | Delaware Division of Corporations | |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.3% | Delaware Division of Corporations | |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 3% | Delaware Division of Corporations |
Officers
5
The Chief Strategy Officer of CATALYST PHARMACEUTICALS, INC. currently on record is Preethi Sundaram Ph.d.; five officers are currently on record for CATALYST PHARMACEUTICALS, INC., filed with Delaware Division of Corporations.
The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at CATALYST PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
CATALYST PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
CATALYST PHARMACEUTICALS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CATALYST PHARMACEUTICALS, INC.?
Five shareholders are currently on record for CATALYST PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 10.7% — the largest recorded stake — followed by iShares Trust-iShares Core S&P Small-Cap ETF at 8.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CATALYST PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CATALYST PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CATALYST PHARMACEUTICALS, INC. have on record?
5 shareholders are shown on record for CATALYST PHARMACEUTICALS, INC.. The register reports 9 in total; only the top 5 by holding are shown here.
What is CATALYST PHARMACEUTICALS, INC.'s company registration number?
CATALYST PHARMACEUTICALS, INC.'s registration number is 4193720, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is CATALYST PHARMACEUTICALS, INC. still an active company?
CATALYST PHARMACEUTICALS, INC.'s status on Delaware Division of Corporations is listed as active.
When was CATALYST PHARMACEUTICALS, INC. incorporated?
CATALYST PHARMACEUTICALS, INC. was incorporated on 7 September 2007, according to Delaware Division of Corporations.
What is CATALYST PHARMACEUTICALS, INC.'s registered address?
The registered address on file for CATALYST PHARMACEUTICALS, INC. is United States.
Who are the officers/directors of CATALYST PHARMACEUTICALS, INC.?
The Chief Strategy Officer of CATALYST PHARMACEUTICALS, INC. currently on record is Preethi Sundaram Ph.d.; five officers are currently on record for CATALYST PHARMACEUTICALS, INC., filed with Delaware Division of Corporations. Management authority at CATALYST PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does CATALYST PHARMACEUTICALS, INC. have a parent company or subsidiaries?
CATALYST PHARMACEUTICALS, INC. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to CATALYST PHARMACEUTICALS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to CATALYST PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CATALYST PHARMACEUTICALS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CATALYST PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.